AKBA
Akebia Therapeutics, Inc.
0.8011$
-1.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 0.05 | 0.00 | 0.04 | 4.09 | 1.78 | 2.83 | 2.13 | 1.29 | 1.60 | 1.04 | 0.76 | 0.92 | |
| – | – | 1.51 | 0.00 | 3.07 | 0.01 | 0.07 | 1.23 | 2.14 | 0.92 | 0.12 | 0.40 | 0.30 | 0.15 | |
| – | – | -1.51 | 0.00 | -3.03 | 4.08 | 1.71 | 1.60 | 0.00 | 0.36 | 1.48 | 0.64 | 0.46 | 0.77 | |
| 0.56 | 0.72 | 1.65 | 1.63 | 3.07 | 5.31 | 2.49 | 2.73 | 1.58 | 0.89 | 0.91 | 0.34 | 0.18 | 0.24 | |
| 0.29 | 0.35 | 0.81 | 0.70 | 0.59 | 0.62 | 0.75 | 1.29 | 1.14 | 1.07 | 0.72 | 0.02 | 0.48 | 0.42 | |
| 0.84 | 1.07 | 2.46 | 2.32 | 3.66 | 5.93 | 3.24 | 4.02 | 2.71 | 1.96 | 1.92 | 0.89 | 0.70 | 0.67 | |
| -0.84 | -1.07 | -2.46 | -2.32 | -3.62 | -1.84 | -1.52 | -2.42 | -2.72 | -1.60 | -0.44 | -0.25 | -0.24 | 0.09 | |
| 0.16 | 0.05 | 0.01 | 0.02 | 0.02 | 0.06 | 0.05 | 0.33 | 0.06 | 0.12 | 0.09 | 0.03 | 0.09 | 0.09 | |
| -0.81 | -0.88 | -2.40 | -2.29 | -3.60 | -1.77 | -1.47 | -2.42 | -2.77 | -1.70 | -0.52 | -0.28 | -0.33 | -0.01 | |
| 0.16 | 0.12 | -0.01 | -0.02 | -0.02 | -0.06 | -0.24 | -0.06 | -0.24 | -0.23 | 0.07 | 0.22 | – | 0.01 | |
| -0.81 | -0.88 | -2.40 | -2.29 | -3.60 | -1.77 | -1.47 | -2.36 | -2.53 | -1.48 | -0.52 | -0.28 | -0.33 | -0.02 | |
| -0.84 | -0.84 | -2.46 | -2.32 | -3.61 | -1.75 | -1.50 | -2.09 | -2.48 | -1.37 | 0.02 | -0.04 | -0.07 | 0.08 |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.